Tagged with P

UAE PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.   The Middle East and North Africa region is comprised of 22 countries and has a population of nearly 400 million. The region is home to a fast-growing pharma market…

Generics Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide association for the generics and biosimilars industries. Stoller plans to focus his efforts on improving access to generics and biosimilars in Europe, as well as tackling the damaging issue of…

China Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the potential to lead the global pharmaceutical industry in this vital area.   Through exchanges with public officials, academics, representatives of patient associations and industry experts, we sensed a paradigm shift The 8th…

Opinion Within the pharmaceutical space, Eurasia Group’s Aditya Bhattacharji expects politics to drive significant changes in regulatory and legal affairs. He explains how the evolving dynamics can be characterized by two themes.   Regulatory Right-Sizing The status quo is highly unlikely to hold in the regulatory space. The growing and largely…

Puerto Rico Jim O’Drobinak, CEO of MCS, one the three largest insurance providers in Puerto Rico, talks about the issues facing the island’s healthcare system, namely chronic underfunding, ageing demography and emigration of doctors, and what the company is doing to tackle these problems. He also stresses the importance of acting on…

UAE The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales, followed by GSK on 129 million and AstraZeneca with 126 million.   Made with Visme Infographic Maker

Oncology Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country’s innovative pharma association has taken the initiative to suggest measures that it believes would drastically improve cancer mortality rates and quality of life for oncology patients.   Recent statistics show that…

China Download our latest pharma country report on China here   2019 is a landmark year for China, marking not only the 70th anniversary of the establishment of the People’s Republic of China by Chairman Mao Zedong in 1949 but also the economic ‘opening up’ and liberalization in 1979 by Premier…

Puerto Rico Michelle Valsega, regional airfreight product director pharma & healthcare for Kuehne and Nagel, shares the latest healthcare logistics trends impacting Puerto Rico and how Kuehne + Nagel uses the island as a centre of innovation to launch and test new solutions.   Kuehne + Nagel has the ambition to be…

Thailand The Pharmaceutical Research and Manufacturers Association (PReMA) has been a key stakeholder in promoting the value of innovation in Thailand for over 100 years. CEO Dr Busakorn Lerswatanasivalee discusses the changes taking place in the Thai healthcare ecosystem and highlights the key initiatives undertaken by PReMA to widen access to,…

Pfizer Selim Sezgin, country manager and managing director of Pfizer Thailand, highlights the recent transformation of the affiliate to adapt to Thailand’s changing climate, as well as the vision of Pfizer in driving impactful partnerships with government and medical stakeholders to drive innovation access for Thai patients.   Pfizer’s new tagline…

Sweden The Swedish Association of Local Authorities and Regions (SALAR) is an employer’s organization that represents and advocates for local government in Sweden. Its chairman, Anders Knape, discusses their work on behalf of the public sector stakeholders, Sweden’s role as an innovation hub, and the opportunities of embracing digitalization.     An…